Quantcast
WebProNews Ad Rates Click Now!
Read WebProNews
With Friends!
 
Pharmaceuticals Articles
Cholesterol Drug Tredaptive Pulled Worldwide

Cholesterol Drug Tredaptive Pulled Worldwide

By Sean Patterson January 14, 2013 | 7 Comments

Less than one month ago, Merck, a major U.S. pharmaceutical company, announced that its cholesterol drug Tredaptive failed a major clinical trial. The drug is meant to improve heart health by increasing levels of “good” cholesterol, but the trial found …

Cholesterol Meds Most Effective With Exercise Cholesterol Meds Most Effective With Exercise
By · November 28, 2012

A new study shows that cholesterol-lowering drugs have a more significant effect when combined with exercise. Though both the drugs and exercise lower the chances of premature death for people with high colesterol, their combined use staved off death better …

Science
Grapefruit Warning For Medications Expanded Grapefruit Warning For Medications Expanded
By · November 28, 2012

A review published this week in the Canadian Medical Association Journal (CMAJ) warns that while the number of prescription drugs that have adverse effects from interactions with grapefruit are increasing, many doctors may be unaware of the effects. The review …

Science
Diabetes Treatment Shown to Improve Memory Diabetes Treatment Shown to Improve Memory
By · November 21, 2012 · 3 Comments

A new study shows that a drug used to treat insulin resistance in diabetics could improve cognitive performance in some people with Alzheimer’s disease. In the study, published this week in the Journal of Neuroscience, the drug rosiglitazone was used …

Science
Asthma Drug Rejected by U.K.’s NICE Asthma Drug Rejected by U.K.’s NICE
By · November 12, 2012 · 1 Comment

The U.K.’s National Institute for Health and Clinical Excellence (NICE) this weekend issued a draft guidance stating that it does not recommend omalizumab, an asthma medication marketed as Xolair by Novartis Pharmaceuticals. NICE is a U.K. health authority that publishes …

Science
Arthritis Drug Approved by the U.S. FDA Arthritis Drug Approved by the U.S. FDA
By · November 9, 2012

The U.S. Food and Drug Administration this week approved Xeljanz (tofacitinib) for the treatment of moderate to severe rheumatoid arthritis (RA) in adults who have not responded to methotrexate. The twice-daily pill works by blocking molecules known as “Janus kinases.” …

Science
Multiple Sclerosis Drug ‘Reboots’ the Immune System Multiple Sclerosis Drug ‘Reboots’ the Immune System
By · November 1, 2012 · 26 Comments

New trials show that a cancer drug can be an effective treatment for multiple sclerosis (MS) by ‘rebooting’ patients’ immune systems. The results of two phase III clinical trials were published today in the journal The Lancet. The trials, sponsored …

Science
Noteworthy Videos
Cholesterol Drug Wins FDA Recommendation Cholesterol Drug Wins FDA Recommendation
By · October 22, 2012 · 3 Comments

Isis Pharmaceuticals recently announced that the Endocrinologic and Metabolic Drugs Advisory Committee of the U.S. Food and Drug Administration (FDA) found the company’s drug, Kynamro (the trade name for mipomersen sodium) has been demonstrated to exhibit “sufficient” efficacy and safety …

Science
Cancer Treatment Kevetrin Begins Clinical Trials Cancer Treatment Kevetrin Begins Clinical Trials
By · October 8, 2012 · 7 Comments

Today the Cellceutix Corporation announced that its new anti-cancer drug candidate Kevetrin will soon be entering clinical trials at the Harvard Cancer Center’s Dana-Farber Cancer Institute and Beth Israel Deaconess Medical Center. Cellceutix is a biopharmaceutical company focused on small …

Science
In The Newsletter
Cancer Treatment for Colorectal Cancer Approved Cancer Treatment for Colorectal Cancer Approved
By · September 28, 2012 · 1

The U.S. Food and Drug Administration (FDA) this week announced that it has approved a new drug for the treatment of colorectal cancer. According to the U.S. Centers for Disease Control and Prevention (CDC), colorectal cancer is the third most …

New MS Treatment Shown to Reduce Relapses New MS Treatment Shown to Reduce Relapses
By · September 21, 2012

Two phase 3 clinical trials have shown that oral doses of a drug called BG-12 show “significant” and “clinically meaningful” reductions in multiple sclerosis (MS) relapses and brain lesions in people with a relapsing form of MS. The active ingredient …

Multiple Sclerosis Pill Approved by U.S. FDA Multiple Sclerosis Pill Approved by U.S. FDA
By · September 14, 2012 · 16

The U.S. FDA this week approved a once-a-day pill for the treatment of multiple sclerosis (MS). The pill, being branded as “Aubagio” by Sanofi S.A., is specifically for the treatment of adults with relapsing forms of MS. “In a clinical …

Leukemia Drug Approved by the FDA Leukemia Drug Approved by the FDA
By · September 7, 2012 · 4

Pfizer this week announced that Bosulif, a medication it developed for the treatment of a rare type of Leukemia, has been approved by the U.S. Food and Drug Administration. The medication is approved for the treatment of adults with chronic, …

HIV Treatment Approved by the FDA HIV Treatment Approved by the FDA
By · August 28, 2012 · 4

Gilead Sciences, a biotech research company, announced today that its new HIV treatment drug has been approved by the U.S. Food and Drug Administration. Dubbed Stribild, the once-daily tablet is made up of four different compounds and designed for those …

Lung Disease Drug Trials Point Toward Approval Lung Disease Drug Trials Point Toward Approval
By · August 27, 2012 · 1

GlaxoSmithKline (GSK) this week announced that phase III of trials for its new long-acting muscarinic antagonist/long-acting beta2 agonist (LAMA/LABA) drug are complete. The drug, which is administered via inhaler, is a once-daily medicine for treatment of chronic obstructive pulmonary disease …

New SmartPill Broadcasts to iPhone New SmartPill Broadcasts to iPhone
By · February 16, 2012

According to a new article in Chemical & Engineering News, the weekly newsmagazine of the American Chemical Society, drug companies have been studying a pill containing a biodegradable chip that can transmit information to a user’s iPhone. Proteus Biomedical has …

Are Google Results Hazardous To Your Health?
By · January 8, 2008

First thing’s first: I’m suspicious of the pharmaceutical industry in general. A lot of people are, but as a journalist, suspicion is part of the job. Also, I have the researcher’s tendency toward cyberchondriasis, so take my non-medical expertise for what it’s worth.

Which isn’t much. I put that out there so others won’t have to.

Next Page »
WebProNews Videos | Advertise | About Us | Newsletter | Archive | News Feeds | Terms & Conditions | Contact Us

WebProNews is an iEntry Network ® publication - © 1998-2013 All Rights Reserved.